2017
DOI: 10.3892/ol.2017.7286
|View full text |Cite
|
Sign up to set email alerts
|

Orbital alveolar soft part sarcoma: A report of 8�cases and review of the literature

Abstract: Alveolar soft part sarcoma (ASPS) is a rare soft tissue neoplasm. The incidence of orbital involvement is the highest in ASPS arising in the head and neck region. However, limited information is available regarding its clinical characteristics. The present study presents the clinical manifestations, imaging findings, pathological features, treatment strategies and prognosis records of 8 cases of orbital ASPS over the last 15 years in a single hospital, along with a review of the literature. Included were 3 mal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
42
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(45 citation statements)
references
References 40 publications
0
42
1
Order By: Relevance
“…15 ASPS is characterized by a specific chromosomal alteration, t(X:17)(p11:q25), resulting in fusion of the TFE3 with alveolar soft part sarcoma critical region 1 (ASPSCR1) at 17q25, and by immunohistochemistry, most of the cells show positivity for TFE3, which is considered a very sensitive and specific maker for ASPS. 1 In conclusion, we report the first orbital ASPS from Canada. This tumour can be misdiagnosed due to very low incidence and the absence of characteristic clinical findings.…”
Section: T a G G E D H 1 Case Reportt A G G E D E N Dmentioning
confidence: 67%
See 2 more Smart Citations
“…15 ASPS is characterized by a specific chromosomal alteration, t(X:17)(p11:q25), resulting in fusion of the TFE3 with alveolar soft part sarcoma critical region 1 (ASPSCR1) at 17q25, and by immunohistochemistry, most of the cells show positivity for TFE3, which is considered a very sensitive and specific maker for ASPS. 1 In conclusion, we report the first orbital ASPS from Canada. This tumour can be misdiagnosed due to very low incidence and the absence of characteristic clinical findings.…”
Section: T a G G E D H 1 Case Reportt A G G E D E N Dmentioning
confidence: 67%
“…Out of the 49 cases, 6 patients (12%) died of the disease. 1,2,6 Increasing age, tumour size, and metastatic disease at presentation seem to indicate a poor prognosis. Herein, the patient was 31 years old.…”
Section: T a G G E D H 1 Case Reportt A G G E D E N Dmentioning
confidence: 99%
See 1 more Smart Citation
“…In the cheek ASPS, the mean size was 3.7 cm (range 1.2-10 cm) and mean age was 33.7 years (range 5-57 years), whereas, in general ASPS, the mean size was 6.5 cm (range 1.2-24 cm) and mean age was 25 years (range 1-78 years) [1,[4][5][6][7][8][9][10][11][12]. The median size of lingual ASPS was 2.5 cm and that of orbital ASPS was 2.85 cm [19,20]. The median age of lingual ASPS was 5 years and that of orbital ASPS was 12 years [19,20].…”
Section: Discussionmentioning
confidence: 99%
“…The median size of lingual ASPS was 2.5 cm and that of orbital ASPS was 2.85 cm [19,20]. The median age of lingual ASPS was 5 years and that of orbital ASPS was 12 years [19,20]. The rarity of ASPS in the head and neck region makes the determination of prognostic factors for survival difficult.…”
Section: Discussionmentioning
confidence: 99%